Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Market Access

NHS to offer Wegovy to a million more people in England

 April 1, 2026

Pharmaphorum

The NHS in England will make Novo Nordisk’s Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.

Market AccessMetabolic & GLP-1Read full story

Post navigation

S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation-Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD →
← ACC 2026: Tonlamarsen lowers angiotensinogen without extra BP benefit

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com